4.5 Article

Incidence, angiographic features and outcomes of patients presenting with subtle ST-elevation myocardial infarction

Journal

AMERICAN HEART JOURNAL
Volume 168, Issue 6, Pages 884-890

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2014.08.009

Keywords

-

Ask authors/readers for more resources

Background Borderline electrocardiograms represent a challenge in ST-segment elevation myocardial infarction (STEMI) management and are associated with inappropriate discharges and delays to intervention. Objectives To assess angiographic characteristics and outcomes of patients presenting with subtle ST-elevation (STE) myocardial infarction. Methods A total of 504 consecutive patients with suspected STEMI treated by systematic primary percutaneous coronary intervention were prospectively included. Subtle STE was defined as a maximal preinterventional STE of 0.1 to 1 mm. Angiograms were interpreted by investigators unaware of the electrocardiographic data. Results The proportion of patients with subtle STE was 18.3%, 86% of them presented with Thrombolysis In Myocardial Infarction flow grade 0/1 and 91% underwent percutaneous coronary intervention. Despite having smaller infarcts, subtle STE patients associated more frequent multivessel disease (57% vs 44%, P = .02) and larger delays to reperfusion. During a follow-up of 19.0 +/- 4.9 months, the rates of death or reinfarction were similar among groups (10.0% vs 12.6%, P = .467). Subtle STE was not associated with better outcomes neither in univariate nor after adjustment in a multivariate analysis (adjusted hazard ratio 0.79, 95% CI 0.37-1.69, P = .546). Conclusions Subtle STEMI is frequent in clinical practice and is usually associated with acute total coronary occlusion. Therefore, it should be diagnosed and treated in the same expeditiously manner as marked STEMI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Ivabradine in acute heart failure: Effects on heart rate and hemodynamic parameters in a randomized and controlled swine trial

Marina Pascual Izco, Rafael Ramirez-Carracedo, Ignacio Hernandez Navarro, Alvaro Osorio Ruiz, Borja Castejon Navarro, Irene Cuadrado Berrocal, Carlota Largo Aramburu, Gonzalo Luis Alonso Salinas, Javier Diez, Marta Saura Redondo, Jose Luis Zamorano, Carlos Zaragoza, Marcelo Sanmartin

CARDIOLOGY JOURNAL (2020)

Editorial Material Cardiac & Cardiovascular Systems

Invasive management in acute non-ST-segment elevation coronary syndromes: be quick or be dead?

Marcelo Sanmartin Fernandez, Maria Abellas Sequeiros

REVISTA ESPANOLA DE CARDIOLOGIA (2020)

Article Cardiac & Cardiovascular Systems

A genetic risk score predicts recurrent events after myocardial infarction in young adults

Luis M. Rincon, Marcelo Sanmartin, Gonzalo L. Alonso, Jose Antonio Rodriguez, Alfonso Muriel, Eduardo Casas, Miguel Navarro, Alejandra Carbonell, Carla Lazaro, Sara Fernandez, Paz Gonzalez, Macarena Rodriguez, Manuel Jimenez-Mena, Covadonga Fernandez-Golfin, Amparo Esteban, Maria Laura Garcia-Bermejo, Jose L. Zamorano

REVISTA ESPANOLA DE CARDIOLOGIA (2020)

Letter Cardiac & Cardiovascular Systems

COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality

Angel Sanchez-Recalde, Jorge Solano-Lopez, Javier Miguelena-Hycka, Jesus Javier Martin-Pinacho, Marcelo Sanmartin, Jose L. Zamorano

REVISTA ESPANOLA DE CARDIOLOGIA (2020)

Article Cardiac & Cardiovascular Systems

Telemedicine consultation for the clinical cardiologists in the era of COVID-19: present and future. Consensus document of the Spanish Society of Cardiology

Vivencio Barrios, Juan Cosin-Sales, Marisol Bravo, Carlos Escobar, Jose M. Gamez, Ana Huelmos, Carolina Ortiz Cortes, Isabel Egocheaga, Jose Manuel Garcia-Pinilla, Javier Jimenez-Candil, Esteban Lopez-de-Sa, Javier Torres Llergo, Juan Carlos Obaya, Vicente Pallares-Carratala, Marcelo Sanmartin, Rafael Vidal-Perez, Angel Cequier

REVISTA ESPANOLA DE CARDIOLOGIA (2020)

Article Biochemistry & Molecular Biology

Ivabradine-Stimulated Microvesicle Release Induces Cardiac Protection against Acute Myocardial Infarction

Rafael Ramirez-Carracedo, Laura Tesoro, Ignacio Hernandez, Javier Diez-Mata, Laura Botana, Marta Saura, Marcelo Sanmartin, Jose Luis Zamorano, Carlos Zaragoza

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cardiac & Cardiovascular Systems

Temporal trends in postinfarction ventricular septal rupture: the CIVIAM Registry

Juan Diego Sanchez Vega, Gonzalo Luis Alonso Salinas, Jose Maria Vieitez Florez, Albert Ariza Sole, Esteban Lopez de Sa, Ricardo Sanz Ruiz, Virginia Burgos Palacios, Sergio Raposeiras-Roubin, Susana Gomez Varela, Juan Sanchis, Lorenzo Silva Melchor, Xurxo Martinez-Seara, Lorena Malagon Lopez, Jose Luis Zamorano Gomez, Marcelo Sanmartin Fernandez

Summary: Postinfarction ventricular septal rupture carries a high mortality risk, but there is a trend towards younger patients over the past decade. In the second time period, there was a significant decrease in one-year mortality and an increase in the use of venoarterial extracorporeal membrane oxygenation, leading to higher survival rates.

REVISTA ESPANOLA DE CARDIOLOGIA (2021)

Article Cardiac & Cardiovascular Systems

In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

Marcelo Sanmartin-Fernandez, Sergio Raposeiras-Roubin, Manuel Anguita-Sanchez, Francisco Marin, Maria Garcia-Marquez, Cristina Fernandez-Perez, Jose-Luis Bernal-Sobrino, Francisco Javier Elola-Somoza, Hector Bueno, Angel Cequier

Summary: Mechanical complications are common in myocardial infarction patients, with a high in-hospital mortality rate. There has been no significant improvement in survival rates of these complications over the past few years. Advanced age, cardiogenic shock, and cardio-respiratory failure are the most important risk factors for in-hospital mortality. Patients have better outcomes in cardiac intensive care units with more experience and specialization.

CARDIOLOGY JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Ivabradine induces cardiac protection by preventing cardiogenic shock-induced extracellular matrix degradation

Laura Tesoro, Rafael Ramirez-Carracedo, Ignacio Hernandez, Javier Diez-Mata, Marina Pascual, Marta Saura, Marcelo Sanmartin, Jose Luis Zamorano, Carlos Zaragoza

Summary: In addition to reducing heart rate by blocking the I(f) current, ivabradine may induce cardiac protection by inhibiting ECM degradation through preservation of the caveolin-3/LG-EMMPRIN complex and control heart rate by stabilizing the caveolin-3/HCN4 complex.

REVISTA ESPANOLA DE CARDIOLOGIA (2021)

Letter Cardiac & Cardiovascular Systems

Monitoring of QTc interval in patients with COVID-19. First experience with a portable ECG-recording device

Maria Abellas-Sequeiros, Cristina Lozano-Granero, Cristina Garcia-Sebastian, Eduardo Franco-Diez, Antonio Hernandez-Madrid, Javier Moreno-Planas, Jaime Masjuan-Vallejo, Marcelo Sanmartin-Fernandez, Jose Luis Zamorano-Gomez

CARDIOLOGY JOURNAL (2021)

Article Health Care Sciences & Services

Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)

Marcelo Sanmartin Fernandez, Francisco Marin, Carles Rafols, Fernando Arribas, Vivencio Barrios, Juan Cosin-Sales, Manuel Anguita Sanchez

Summary: In clinical practice, most patients receive the appropriate dosage of rivaroxaban. However, older age and renal insufficiency are associated with inadequate dosing. Underdosed patients had a slightly higher all-cause mortality rate, while overdosed patients had a higher rate of bleeding events.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2021)

Letter Cardiac & Cardiovascular Systems

Theophylline for Attenuating Ticagrelor-Related Dyspnea

Marcelo Sanmartin-Fernandez, Jose Luis Zamorano

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2021)

Meeting Abstract Cardiac & Cardiovascular Systems

Predictors of adverse clinical outcomes in atrial fibrillation patients with concomitant renal impairment under rivaroxaban therapy

F. Marin, J. M. Rivera-Caravaca, M. Anguita Sanchez, M. Sanmartin Fernandez, C. Rafols, V. Roldan, E. Recalde, R. Freixa Pamias, I. Lekuona Goya, J. M. Vazquez Rodriguez, A. Perez Cabeza

EUROPEAN HEART JOURNAL (2021)

Review Clinical Neurology

Optimizing the detection of subclinical atrial fibrillation after ESUS

Jaime Masjuan, Marcelo Sanmartin-Fernandez, Ignacio Ferreira-Gonzalez, Carlos Molina

Summary: Approximately 20% of ischemic strokes may have a cardioembolic origin, emphasizing the importance of adequate diagnostic approach for ESUS to optimize antithrombotic treatment. Detection of atrial fibrillation is crucial for treatment optimization, yet not all patients have the same risk of developing silent atrial fibrillation, with factors such as left atrium enlargement, elderly age, and frequent premature supraventricular complexes increasing the risk. A more prolonged monitorization may increase the possibility of detecting atrial fibrillation in these high-risk patients, leading to improved outcomes with anticoagulant treatment.

REVISTA DE NEUROLOGIA (2021)

Article Cardiac & Cardiovascular Systems

Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak

Jorge Solano-Lopez, Jose Luis Zamorano, Ana Pardo Sanz, Ignacio Amat-Santos, Fernando Sarnago, Enrique Gutierrez Ibanes, Juan Sanchis, Juan Ramon Rey Blas, Joan Antoni Gomez-Hospital, Sandra Santos Martinez, Nicolas Manuel Maneiro-Melon, Roberto Mateos Gaitan, Jessika Gonzalez D'Gregorio, Luisa Salido, Jose L. Mestre, Marcelo Sanmartin, Angel Sanchez-Recalde

REVISTA ESPANOLA DE CARDIOLOGIA (2020)

Article Cardiac & Cardiovascular Systems

Realtime Diagnosis from Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation with Long Follow-Up (REGAL): Rationale and design of a pragmatic, decentralized, randomized controlled trial

Xiaoxi Yao, Zachi I. Attia, Emma M. Behnken, Melissa S. Hart, Shealeigh A. Inselman, Kayla C. Weber, Fan Li, Nikki H. Stricker, John L. Stricker, Paul A. Friedman, Peter A. Noseworthy

Summary: This study aims to explore whether Apple Watch, used as a long-term monitoring device, is effective in the early diagnosis of atrial fibrillation (AF) and the prevention of cognitive function decline in older adults. By using AI-ECG to screen high-risk patients and record electrocardiograms, the effectiveness of Apple Watch will be evaluated. If successful, this approach could have significant implications on how future clinical practice leverages consumer devices for early diagnosis and disease prevention.

AMERICAN HEART JOURNAL (2024)